Literature DB >> 9267938

Vasopressin pressor hypersensitivity in vasodilatory septic shock.

D W Landry1, H R Levin, E M Gallant, S Seo, D D'Alessandro, M C Oz, J A Oliver.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9267938     DOI： 10.1097/00003246-199708000-00012

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  61 in total

Review 1.  New evidence for old therapies in catecholamine-dependent septic shock.

Authors:  J O Friedrich; S E Lapinsky
Journal:  Intensive Care Med       Date:  2001-04       Impact factor: 17.440

Review 2.  Terlipressin in chronic hyperdynamic endotoxic shock: is it safe?

Authors:  Pierre Asfar
Journal:  Intensive Care Med       Date:  2003-02       Impact factor: 17.440

3.  Impact of low-dose vasopressin on trauma outcome: prospective randomized study.

Authors:  Stephen M Cohn; Janet McCarthy; Ronald M Stewart; Rachelle B Jonas; Daniel L Dent; Joel E Michalek
Journal:  World J Surg       Date:  2011-02       Impact factor: 3.352

4.  Cardiovascular Responsiveness to Vasopressin and α1-Adrenergic Receptor Agonists After Burn Injury.

Authors:  Ann E Evans; P Geoff Vana; Heather M LaPorte; Richard H Kennedy; Richard L Gamelli; Matthias Majetschak
Journal:  J Burn Care Res       Date:  2017 Mar/Apr       Impact factor: 1.845

Review 5.  Clinical sepsis and septic shock--definition, diagnosis and management principles.

Authors:  Jean-Louis Vincent
Journal:  Langenbecks Arch Surg       Date:  2008-06-27       Impact factor: 3.445

Review 6.  AKI associated with cardiac surgery.

Authors:  Robert H Thiele; James M Isbell; Mitchell H Rosner
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-06       Impact factor: 8.237

7.  The Japanese guidelines for the management of sepsis.

Authors:  Shigeto Oda; Mayuki Aibiki; Toshiaki Ikeda; Hitoshi Imaizumi; Shigeatsu Endo; Ryoichi Ochiai; Joji Kotani; Nobuaki Shime; Osamu Nishida; Takayuki Noguchi; Naoyuki Matsuda; Hiroyuki Hirasawa
Journal:  J Intensive Care       Date:  2014-10-28

Review 8.  Management of vasodilatory shock: defining the role of arginine vasopressin.

Authors:  Martin W Dunser; Volker Wenzel; Andreas J Mayr; Walter R Hasibeder
Journal:  Drugs       Date:  2003       Impact factor: 9.546

9.  Phosphoinositide 3-Kinase Is Involved in Mediating the Anti-inflammation Effects of Vasopressin.

Authors:  Woan-Ching Jan; Ming-Chang Kao; Chen-Hsien Yang; Ya-Ying Chang; Chun-Jen Huang
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

10.  Low-dose vasopressin infusion results in increased mortality and cardiac dysfunction following ischemia-reperfusion injury in mice.

Authors:  Toonchai Indrambarya; John H Boyd; Yingjin Wang; Melissa McConechy; Keith R Walley
Journal:  Crit Care       Date:  2009-06-23       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.